Enhancing the antibacterial effect of chitosan to combat orthopaedic implant-associated infections.
dc.contributor.author | Rahayu, Dien Puji | |
dc.contributor.author | De Mori, Arianna | |
dc.contributor.author | Yusuf, Rahmi | |
dc.contributor.author | Draheim, Roger | |
dc.contributor.author | Lalatsa, Aikaterini | |
dc.contributor.author | Roldo, Marta | |
dc.date.accessioned | 2024-09-24T14:01:37Z | |
dc.date.available | 2024-09-24T14:01:37Z | |
dc.date.issued | 2022-03-28 | |
dc.description | open access article SDG3 | |
dc.description.abstract | The development of antibacterial resistance imposes the development of novel materials to relieve the burden of infection. Chitosan, a material of natural and sustainable origin, possesses ideal characteristics to translate into a novel biomaterial with antibacterial properties, as it already has these properties and it allows easy and scalable chemical modification to enhance its activity. The aim of the present work was that of producing low molecular weight chitosans that have higher solubility and can remain protonated at physiological pH, thus enhancing the antimicrobial action. This was achieved by reacting acid hydrolysed low molecular weight chitosan with 2-bromoethyleneamine hydrobromide or Fmoc-Lys(Fmoc)-OH to elicit N-(2-ethylamino)-chitosan and N-2(2,6-diaminohexanamide)-chitosan polymers. The latter derivative, CS3H Lys, that was synthesised for the first time, showed superior efficacy against Staphylococcus aureus, supporting further studies for its inclusion in implant coating materials to tackle the burden of orthopaedic implant-associated infections. | |
dc.funder | Other external funder (please detail below) | |
dc.funder.other | RISET-Pro by the Ministry of Research, Technology and Higher Education of the Republic of Indonesia | |
dc.identifier.citation | Rahayu, D.P. et al. (2022)Enhancing the antibacterial effect of chitosan to combat orthopaedic implant-associated infections. Carbohydrate Polymers, 289, 119385 | |
dc.identifier.doi | https://doi.org/10.1016/j.carbpol.2022.119385 | |
dc.identifier.uri | https://hdl.handle.net/2086/24257 | |
dc.language.iso | en | |
dc.peerreviewed | Yes | |
dc.projectid | 8245-ID | |
dc.publisher | Elsevier | |
dc.researchinstitute.institute | Leicester Institute for Pharmaceutical and Health Innovations | |
dc.rights | Attribution-NonCommercial 4.0 International | en |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | |
dc.subject | Antibacterial activity | |
dc.subject | Chitosan | |
dc.subject | Chitosan derivatives | |
dc.subject | Implant-associated infection | |
dc.subject | S. aureus | |
dc.title | Enhancing the antibacterial effect of chitosan to combat orthopaedic implant-associated infections. | |
dc.type | Article |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Roldo_Enhancing the antibacterial effect of chitosan to combat orthopaedic implant-associated infections.pdf
- Size:
- 2.94 MB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 4.2 KB
- Format:
- Item-specific license agreed upon to submission
- Description: